XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

Goldstein Advisors, LLC's Holding History (CIK: 0001963807)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 40,000 Value ($000) $220 Avg Close $4.04 Range $3.14 - $6.07
Q4 2024
Shares 37,800 Value ($000) $128 Avg Close $3.22 Range $2.69 - $3.87
Q3 2024
Shares 30,425 Value ($000) $87 Avg Close $2.57 Range $2.03 - $3.04
Q2 2024
Shares 25,425 Value ($000) $57 Avg Close $2.02 Range $1.69 - $2.51
Q1 2024
Shares 25,425 Value ($000) $56 Avg Close $2.59 Range $2.00 - $3.26
Q4 2023
Shares 25,425 Value ($000) $60 Avg Close $1.85 Range $1.46 - $2.44
Q3 2023
Shares 25,425 Value ($000) $47 Avg Close $2.29 Range $1.73 - $2.78
Q2 2023
Shares 25,425 Value ($000) $67 Avg Close $2.55 Range $1.64 - $3.07
Q1 2023
Shares 25,425 Value ($000) $41 Avg Close $1.25 Range $0.97 - $1.70
Q4 2022
Shares 15,425 Value ($000) $21 Avg Close $1.41 Range $1.14 - $1.70